Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Trial details
- Registry ID
- NCT03257033
- Phase
- Phase 3
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPCNCT03257033 | RenovoRx | Phase 3 | Active not recruiting | 2027-06Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |